A NEUROPHARMACOLOGICAL INVESTIGATION OF SOME TRANS-TETRAHYDROCANNABINOL DERIVATIVES

被引:98
作者
LIPPARIN.F
DECAROLI.AS
LONGO, VG
机构
[1] Laboratori di Chimica Terapeutica, Istituto Superiore di Sanità, Roma
关键词
Conditioned behavior; EEG; Hallucinogens; Tetrahydrocannabinols;
D O I
10.1016/0031-9384(69)90149-8
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
A study of the central action of six cannabinoids has been carried out. The compounds studies (see table) were (-)Δ9THC and (-)Δ8THC, the racemic Δ8THC, the α methyl, and α, α dimethyl derivatives of (-)Δ8THC, and (-)cannabidiol. The effects of these drugs have been studied on the cerebral electrical activity and on spontaneous and conditioned behavior of cats, rabbits, and rats with chronically implanted electrodes. In the rabbit and in the rat, (-)Δ9THC, (-)Δ8THC, and the two methylated derivatives of (-)Δ8THC proved to have a similar effect; they induced a flattening of the EEG tracing, the disruption of the theta waves of the hippocampus and they gave rise to trains of high voltage spike-and-waves. These EEG modifications were accompanied by corneal arreflexia and other signs of motor deficit, together with a state of excitation and a reduced response to painful stimuli. The racemic Δ8THC, although provoking the same picture, proved less active. (-)Cannabidiol provoked motor paralysis and corneal arreflexia, these symptoms were accompanied by an EEG synchronization. In the cat, the performance of a conditioned instrumental discrimination exercise was blocked by the administration of 2 mg/kg of Δ9THC; this effect was accompanied by a synchronization of the EEG. These results are discussed also in relation to the human effect of some of these compounds. It is suggested that the flattening of the EEG and the appearance of the spike-and-waves may be the EEG counterpart of the psychodysleptic action of the tetrahydrocannabinols in man. © 1969.
引用
收藏
页码:527 / &
相关论文
共 18 条
[1]  
ADAMS R, 1941, HARVEY LECT, P168
[2]  
BARAN L, 1964, ACTA PHYSIOL LAT AM, V14, P125
[3]  
BICHER HI, 1968, ARCH INT PHARMACOD T, V172, P24
[4]  
BOYD ES, 1965, J PHARMACOL EXP THER, V149, P138
[5]  
CLAUSSEN U, 1966, Z NATURFORSCH PT B, VB 21, P594
[6]  
CORRADO A P, 1961, Arch Int Pharmacodyn Ther, V132, P255
[7]  
DOMINO EF, 1955, J PHARMACOL EXP THER, V115, P449
[8]   ISOLATION, STRUCTURE, AND PARTIAL SYNTHESIS OF AN ACTIVE CONSTITUENT OF HASHISH [J].
GAONI, Y ;
MECHOULAM, R .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1964, 86 (08) :1646-+
[9]  
GAYER HERMANN, 1928, ARCH EXP PATH UND PHARMA KOL, V129, P312
[10]   PSYCHOPHARMACOLOGICAL ACTIVITY OF ACTIVE CONSTITUENTS OF HASHISH AND SOME RELATED CANNABINOIDS [J].
GRUNFELD, Y ;
EDERY, H .
PSYCHOPHARMACOLOGIA, 1969, 14 (03) :200-&